Use of Human Cell Lines Versus Primary Cells in Drug Discovery

Learn about applications and considerations for human cell lines and primary cells in drug discovery.

Drug discovery is a complex process that involves the identification and validation of potential therapeutic compounds. One of the critical aspects of this process is the use of cellular models to test the efficacy, safety, and mechanisms of action of these compounds. Human cell lines and primary cells are two fundamental types of cellular models employed in drug discovery. Each offers unique advantages and poses distinct challenges, making the choice between them crucial for the success of drug development programs. We will explain here the characteristics of human cell lines and primary cells, their roles in drug discovery, the methodologies employed, and the considerations influencing their use.

Human Cell Lines in Drug Discovery

Human cell lines are immortalized cells that can proliferate indefinitely in vitro. They are typically derived from cancerous tissues or transformed by viruses, chemicals, or genetic manipulation to bypass normal cellular senescence. Some of the most commonly used human cell lines in drug discovery include HeLa (cervical cancer), HEK293 (human embryonic kidney), and A549 (lung carcinoma) cells.

Advantages of Human Cell Lines

1. Reproducibility: Human cell lines provide a consistent and reproducible model system. Their ability to proliferate indefinitely ensures a continuous and uniform supply of cells, facilitating standardized experimental conditions.

2. Ease of Use: Cell lines are relatively easy to culture and maintain, requiring fewer specialized techniques compared to primary cells. This ease of use makes them ideal for high-throughput screening (HTS) and large-scale studies.

3. Cost-Effectiveness: Due to their immortal nature, cell lines are more cost-effective over time, as they eliminate the need for repeated isolation and preparation of new cell batches.

4. Genetic Manipulation: Human cell lines are amenable to genetic manipulation, allowing researchers to introduce specific mutations, knockdowns, or overexpressions to study gene function and drug responses.

Applications of Human Cell Lines

Human cell lines are extensively used in various stages of drug discovery:

1. Target Identification and Validation: Cell lines are employed to identify and validate drug targets, such as receptors, enzymes, or signaling molecules, by studying the effects of genetic or pharmacological modulation.

2. High-Throughput Screening: Cell lines are the workhorses of HTS, enabling the rapid screening of large compound libraries to identify potential drug candidates.

3. Mechanistic Studies: Researchers use cell lines to investigate the mechanisms of action of drugs at the molecular and cellular levels, providing insights into their effects on cellular pathways.

4. Toxicology and Safety Assessments: Cell lines are utilized to evaluate the cytotoxicity and safety profiles of drug candidates, helping to predict potential adverse effects.

Primary Cells in Drug Discovery

Primary cells are directly isolated from human tissues and retain many of the physiological characteristics of their tissue of origin. These cells are not immortalized and have a limited lifespan in vitro, often undergoing senescence after a finite number of cell divisions. Examples of primary cells used in drug discovery include human peripheral blood mononuclear cells (PBMCs), hepatocytes, and cardiomyocytes.

Advantages of Primary Cells

1. Physiological Relevance: Primary cells closely mimic the in vivo environment and exhibit more accurate physiological and biochemical properties compared to immortalized cell lines. This makes them more predictive of human responses to drugs.

2. Genotypic and Phenotypic Fidelity: Primary cells retain the genotypic and phenotypic characteristics of the donor tissue, providing a more relevant model for studying specific diseases and patient-specific responses.

3. Diversity: Primary cells can be obtained from a variety of tissue types and donors, allowing for the study of diverse genetic backgrounds and disease states.

Applications of Primary Cells

Primary cells are employed in several key areas of drug discovery:

1. Disease Modeling: Primary cells from patients with specific diseases can be used to create in vitro disease models, facilitating the study of disease mechanisms and the identification of therapeutic targets.

2. Pharmacokinetics and Metabolism: Hepatocytes and other primary cells are used to study drug metabolism and pharmacokinetics, providing insights into how drugs are processed in the human body.

3. Toxicology and Safety Testing: Primary cells offer a more accurate assessment of drug toxicity and safety, as they better replicate the cellular responses seen in human tissues.

4. Personalized Medicine: Primary cells from individual patients can be used to test the efficacy and safety of drugs, paving the way for personalized treatment approaches.

Methods and Techniques

Both human cell lines and primary cells require specific methodologies and techniques to ensure reliable and reproducible results in drug discovery:

1. Cell Culture: Standardized protocols for the culture and maintenance of cell lines and primary cells are essential. This includes optimized media, growth conditions, and passaging techniques to maintain cell health and functionality.

2. Genetic Manipulation: Techniques such as CRISPR/Cas9, RNA interference (RNAi), and overexpression systems are used to modify gene expression in cell lines and primary cells, enabling the study of gene function and drug interactions.

3. Omics Technologies: Genomics, transcriptomics, proteomics, and metabolomics are applied to analyze the molecular changes induced by drug treatment, providing comprehensive insights into drug effects and mechanisms.

4. High-Throughput Screening: Automated systems and robotic platforms facilitate the high-throughput screening of compounds using cell lines, enabling the rapid identification of potential drug candidates.

5. 3D Culture and Organoids: Advanced culture techniques, such as three-dimensional (3D) culture and organoid formation, are increasingly used to create more physiologically relevant models that better mimic in vivo conditions.

Challenges and Considerations

The use of human cell lines and primary cells in drug discovery is accompanied by several challenges and considerations:

1. Reproducibility and Standardization: Variability in cell culture conditions, donor variability for primary cells, and genetic drift in cell lines can impact reproducibility. Standardized protocols and quality control measures are essential.

2. Ethical and Regulatory Concerns: The use of human tissues and cells raises ethical and regulatory issues, particularly regarding donor consent and the sourcing of primary cells. Compliance with ethical guidelines and regulations is crucial.

3. Scalability: While cell lines are well-suited for high-throughput applications, primary cells can be limited by their availability and scalability. Efficient isolation and expansion techniques are needed for primary cells.

4. Translatability: Ensuring that in vitro findings translate to in vivo and clinical outcomes remains a significant challenge. Combining in vitro studies with in vivo models and computational approaches can enhance predictive power.

Advancements and Future Directions

Ongoing advancements are addressing some of the challenges associated with the use of human cell lines and primary cells:

1. Induced Pluripotent Stem Cells (iPSCs): iPSCs can be differentiated into various cell types, providing a renewable source of human cells that retain many primary cell characteristics. iPSCs enable the creation of patient-specific disease models and personalized drug testing.

2. CRISPR/Cas9 and Gene Editing: Advanced gene editing technologies are improving the precision and efficiency of genetic modifications in cell lines and primary cells, facilitating the study of gene function and disease mechanisms.

3. Organoids and 3D Models: The development of organoids and 3D culture systems is enhancing the physiological relevance of in vitro models, allowing for more accurate studies of tissue-specific responses and disease processes.

4. Single-Cell Analysis: Single-cell RNA sequencing (scRNA-seq) and other single-cell technologies provide detailed insights into the heterogeneity and specific responses of individual cells, improving our understanding of drug effects at the cellular level.

5. Artificial Intelligence (AI) and Machine Learning: AI and machine learning are being integrated into drug discovery workflows to analyze large datasets, identify patterns, and predict drug responses, enhancing the efficiency and accuracy of drug development.


The use of human cell lines and primary cells is fundamental to the drug discovery process, each offering unique advantages and posing specific challenges. While cell lines provide a consistent and cost-effective model for high-throughput screening and mechanistic studies, primary cells offer greater physiological relevance and genotypic fidelity. Advances in technologies such as iPSCs, gene editing, organoids, and AI are continually improving the capabilities and applications of these cellular models. By leveraging the strengths of both cell lines and primary cells, researchers can enhance the efficiency and effectiveness of drug discovery, ultimately leading to the development of safer and more effective therapies for patients.

Immune Modelling & Experimental Design

Immune Risk Assessment

Tissue Damage & Cytotoxicity

Immuno-Oncology & Immunotoxicity

Inflammation & Systemic Diseases

Vaccines, Drug Delivery & Transfection

Signalling Pathways

Looking for a tailored solution?

Of course, there is no one-size-fits-all solution for most studies. Immundnz specializes in developing tailored assays to enable you to challenge the status quo in your research.


Some of our popular assays

To accelerate your research and deliver high-quality data, Immundnz offers a broad spectrum of standardized, proven assays that are readily available.

M1/M2 Polarisation

M1/M2 are important in studies of various therapeutic areas and biological pathways.



Phagocytosis is an immunologic mechanism involved in apoptosis, necrosis, infection and tumour conditions mediated by leukocytes like macrophages, DCs, and neutrophils. 

Cytokine Release Assay

Cytokine release assay (CRA) is vital in biopharmaceutical discovery and development and life science research.


Dendritic Cell Maturation

Dendritic cells (DCs) are the star antigen-presenting cells (APCs) of myeloid or haematopoietic origin that play a vital role between the innate and adaptive immune systems. 


T Cell Differentiation

The T cell proliferation assay can be used to assess modulation of the T cell response by (immunomodulatory) compounds.


Immune & Protein-Based

We perform various immunologic and protein-based assays that are needed in your research or drug development.


Case Studies

Immundnz has performed many case studies, some of which are described here. You can always reach out to us for other examples of projects we have done.


Immundnz shares insights on in vitro immunology research for drug discovery on its blog, which is regularly updated by experts in the field.